Hemenway Trust Co LLC Has $28.78 Million Stock Holdings in Xylem Inc. (NYSE:XYL)

Hemenway Trust Co LLC cut its stake in shares of Xylem Inc. (NYSE:XYL) by 0.8% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 212,195 shares of the industrial products company’s stock after selling 1,736 shares during the period. Xylem accounts for about 2.5% of Hemenway Trust Co LLC’s investment portfolio, making the stock its 20th biggest holding. Hemenway Trust Co LLC owned 0.09% of Xylem worth $28,780,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of XYL. EverSource Wealth Advisors LLC boosted its position in Xylem by 68.8% during the first quarter. EverSource Wealth Advisors LLC now owns 189 shares of the industrial products company’s stock valued at $25,000 after purchasing an additional 77 shares during the last quarter. Blue Trust Inc. lifted its position in shares of Xylem by 1,185.7% in the second quarter. Blue Trust Inc. now owns 270 shares of the industrial products company’s stock valued at $35,000 after buying an additional 249 shares during the last quarter. FinTrust Capital Advisors LLC lifted its position in shares of Xylem by 170.9% in the first quarter. FinTrust Capital Advisors LLC now owns 317 shares of the industrial products company’s stock valued at $41,000 after buying an additional 200 shares during the last quarter. Hazlett Burt & Watson Inc. lifted its position in shares of Xylem by 184.9% in the first quarter. Hazlett Burt & Watson Inc. now owns 339 shares of the industrial products company’s stock valued at $43,000 after buying an additional 220 shares during the last quarter. Finally, UMB Bank n.a. lifted its position in shares of Xylem by 96.9% in the second quarter. UMB Bank n.a. now owns 382 shares of the industrial products company’s stock valued at $52,000 after buying an additional 188 shares during the last quarter. 87.96% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the company. Oppenheimer increased their target price on Xylem from $147.00 to $152.00 and gave the stock an “outperform” rating in a research note on Friday, May 31st. Robert W. Baird increased their target price on Xylem from $155.00 to $170.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 31st. Argus increased their target price on Xylem from $146.00 to $165.00 and gave the stock a “buy” rating in a research note on Wednesday, May 29th. Royal Bank of Canada raised their price objective on Xylem from $160.00 to $163.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 31st. Finally, Stifel Nicolaus raised their price objective on Xylem from $170.00 to $172.00 and gave the stock a “buy” rating in a research note on Wednesday, July 31st. Five research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $147.54.

Insider Activity at Xylem

In related news, CAO Geri-Michelle Mcshane sold 2,278 shares of the company’s stock in a transaction that occurred on Monday, June 10th. The stock was sold at an average price of $138.63, for a total value of $315,799.14. Following the transaction, the chief accounting officer now owns 3,536 shares in the company, valued at $490,195.68. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 0.27% of the stock is owned by company insiders.

Xylem Stock Down 0.3 %

Shares of NYSE:XYL traded down $0.37 during trading on Friday, reaching $127.66. 237,753 shares of the stock were exchanged, compared to its average volume of 1,211,900. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.85 and a quick ratio of 1.33. The stock has a fifty day moving average of $134.31 and a two-hundred day moving average of $133.68. The firm has a market cap of $31.01 billion, a price-to-earnings ratio of 45.56, a price-to-earnings-growth ratio of 2.27 and a beta of 1.04. Xylem Inc. has a 1-year low of $87.59 and a 1-year high of $146.08.

Xylem (NYSE:XYL) last issued its quarterly earnings data on Tuesday, July 30th. The industrial products company reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.05 by $0.04. The firm had revenue of $2.17 billion during the quarter, compared to analyst estimates of $2.14 billion. Xylem had a return on equity of 9.48% and a net margin of 9.11%. The company’s revenue for the quarter was up 26.0% on a year-over-year basis. During the same period in the previous year, the company posted $0.98 EPS. Research analysts anticipate that Xylem Inc. will post 4.26 earnings per share for the current fiscal year.

Xylem Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 26th. Investors of record on Thursday, August 29th will be paid a $0.36 dividend. The ex-dividend date of this dividend is Thursday, August 29th. This represents a $1.44 annualized dividend and a yield of 1.13%. Xylem’s payout ratio is 51.25%.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.